GlassScriptPhysician profile
Jessica Austel
NPI 1760159487
$777.04
in general payments reported to CMS, 2019-2025
15 companies · $77.97 in 2025
The $77.97 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $267 · 2023: $192 · 2024: $116 · 2025: $77.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $216.45 | 2022-2025 | |
| Novo Nordisk INC | $123.67 | 2021 | |
| Aspira Women'S Health INC | $92.14 | 2022 | |
| Hologic Sales and Service, LLC | $76.83 | 2023-2024 | Aptima, Novasure, Myosure Tissue Removal Device |
| Baxter Healthcare | $49.18 | 2023-2024 | Floseal, Perclot |
| Myriad Women'S Health, INC. | $33.71 | 2023 | Myrisk |
| Exeltis, USA INC. | $33.56 | 2023-2025 | Slynd |
| Merck Sharp & Dohme LLC | $25.94 | 2023-2024 | Gardasil 9, Gardasil, Pneumovax 23 |
| Therapeuticsmd, INC. | $20.61 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.69 | 2022 | |
| Agile Therapeutics, INC. | $17.97 | 2022 | |
| Sumitomo Pharma America, INC. | $17.82 | 2024 | Myfembree |
| Myovant Sciences INC. | $17.30 | 2022 | |
| Astellas Pharma US INC | $16.53 | 2025 | Veozah |
| Pfizer INC. | $15.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Austel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.